DI CHIARA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 5.346
EU - Europa 3.298
AS - Asia 2.553
SA - Sud America 404
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.668
Nazione #
US - Stati Uniti d'America 5.243
IT - Italia 1.067
SG - Singapore 901
RU - Federazione Russa 757
CN - Cina 662
BR - Brasile 318
FI - Finlandia 314
HK - Hong Kong 268
VN - Vietnam 249
DE - Germania 244
UA - Ucraina 206
PL - Polonia 152
GB - Regno Unito 138
FR - Francia 117
IE - Irlanda 116
BD - Bangladesh 114
JP - Giappone 72
IN - India 62
CA - Canada 52
KR - Corea 43
SE - Svezia 42
NL - Olanda 34
MX - Messico 27
AR - Argentina 26
IQ - Iraq 25
BE - Belgio 22
RO - Romania 22
TR - Turchia 22
ZA - Sudafrica 19
AT - Austria 18
EC - Ecuador 16
CL - Cile 15
MY - Malesia 15
PK - Pakistan 15
PH - Filippine 14
VE - Venezuela 14
ES - Italia 12
IR - Iran 11
SA - Arabia Saudita 11
UZ - Uzbekistan 10
NP - Nepal 9
LT - Lituania 8
MA - Marocco 8
CI - Costa d'Avorio 7
CH - Svizzera 6
ID - Indonesia 6
OM - Oman 6
AZ - Azerbaigian 5
CO - Colombia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
ET - Etiopia 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
PY - Paraguay 1
Totale 11.663
Città #
Ashburn 698
Singapore 605
Fairfield 455
San Jose 388
Chandler 330
Hong Kong 263
Woodbridge 260
Seattle 195
Wilmington 186
Houston 169
Ann Arbor 151
Moscow 149
Palermo 146
Council Bluffs 128
Zgierz 128
Dallas 125
Cambridge 123
Dublin 116
New York 114
Beijing 102
Jacksonville 102
Boardman 94
Santa Clara 89
Des Moines 88
Ho Chi Minh City 87
Medford 86
Los Angeles 82
Rome 72
Frankfurt am Main 68
Tokyo 68
Milan 67
Helsinki 63
Nanjing 62
Hefei 59
Altamura 58
The Dalles 58
Lauterbourg 56
Hanoi 55
Princeton 54
Buffalo 49
Lawrence 39
San Diego 37
São Paulo 31
Tulsa 29
Dearborn 28
Jinan 27
Hebei 26
Shenyang 26
Chicago 24
Florence 23
Amsterdam 22
London 22
Nanchang 22
Orem 21
Brussels 20
Columbus 19
Naples 19
Tianjin 17
Changsha 16
Phoenix 16
Da Nang 15
Stockholm 15
Warsaw 15
Denver 14
Johannesburg 14
Seongnam 14
Verona 14
Chennai 13
Falls Church 13
Hangzhou 13
Ludwigshafen am Rhein 13
Montreal 13
Nuremberg 13
Springfield 13
Auburn Hills 12
Guangzhou 12
Kumar 12
Zhengzhou 12
Atlanta 11
Grassobbio 11
Jiaxing 11
Santiago 11
City of London 10
Düsseldorf 10
Mumbai 10
Shanghai 10
Tashkent 10
Toronto 10
Turin 10
Izmir 9
Ottawa 9
Rio de Janeiro 9
San Mateo 9
Tehran 9
Baghdad 8
Bologna 8
Boston 8
Munich 8
Ningbo 8
Poplar 8
Totale 7.179
Nome #
Obesità e rischio cardiovascolare. 582
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 309
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 290
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 255
Genetics and gene therapy of anderson-fabry disease 251
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 244
L’obesità fattore o co-fattore di rischio? 239
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 238
Association between low education and higher global cardiovascular risk 235
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 229
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 227
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 224
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 221
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 219
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 218
Take the wind out your salis: relationship among energy drink abuse, hypertension, and break-up of cerebral aneurysm 213
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 212
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 205
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 204
Education and hypertension: impact on global cardiovascular risk 201
Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk 199
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 198
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 198
Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction 196
Visceral obesity and metabolic syndrome: two faces of the same medal? 194
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 193
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report 192
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. 191
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial 191
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 190
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 188
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 184
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 184
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure 184
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 181
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 181
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 170
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 169
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 164
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 162
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 162
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 161
Pathogenesis and molecular mechanisms of anderson–fabry disease and possible new molecular addressed therapeutic strategies 159
Genetic polymorphisms and cytokine levels in ischemic stroke: associations with subtypes and prognosis 151
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 149
Obesity: a main factor of metabolic syndrome? 149
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 139
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 137
Nutrizione,sovrappeso e sindrome metabolica 137
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review 134
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 134
Iperuricemia: significato clinico e nuove prospettive di trattamento 122
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides 120
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis 116
Sindrome Metabolica 115
La terapia dietetica nell’insufficienza renale cronica. 112
Identification of Novel Mutations in Patients Affected by Gaucher Disease 109
Sindrome metabolica: fatti e compromessi. 109
Scompenso cardiaco da disfunzione diastolica. 107
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 106
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 106
Mediterranean diet and hypertension: relationship between adherence to a Mediterranean diet and arterial hypertension 101
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 92
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 91
Il paziente iperteso ad alto rischio cadiovascolare 81
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 81
null 51
null 42
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on inflammatory, remodelling markers and epigenetics signatures of patients with congestive acute decompensated heart failure (ADHF) 13
Totale 12.011
Categoria #
all - tutte 38.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022725 28 127 16 29 67 27 40 48 77 91 43 132
2022/20231.028 86 166 36 107 99 154 75 78 145 13 43 26
2023/2024466 27 57 20 37 33 94 41 33 8 18 17 81
2024/20251.281 25 78 58 107 52 33 130 77 95 119 187 320
2025/20265.022 339 100 325 353 536 699 743 484 308 556 230 349
2026/2027138 138 0 0 0 0 0 0 0 0 0 0 0
Totale 12.011